AAPS 2009: Innovations-Neotanshinlactone Derivatives

Article

A Joint Presentation of Pharmaceutical Technology and

Young Innovators of 2009: Interviews with AAPS Graduate Student Winners

Neotanshinlactone Derivatives

Subscribe to RSS feed of this series


Yizhou Dong
University of North Carolina, Chapel Hill


Category: DRUG DESIGN AND DISCOVERY


Design, Synthesis, and Biological Evaluation of Novel Neotanshinlactone Derivatives as Potent and Selective Anti-Breast Cancer Agents

View Poster Presentation

Related Articles



Winning Presentations


Listen to the Interviews



AAPS President

Dr. Patrick P. DeLuca, president of AAPS, discusses the organization’s programs and commitment to student scientists.

Listen>>



Recent Videos
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Leroy Hood, MD, PhD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.